World's Best Scientists 2026 revealed!
Award Badge
Medicine
Italy
2023

D-Index & Metrics

Medicine

D-Index
126
Citations
58791
World Ranking
2959
National Ranking
76

Research.com Recognitions

  • 2023 - Research.com Medicine in Italy Leader Award

Overview

Gianluca Gaidano is affiliated with the University of Eastern Piedmont Amadeo Avogadro in Italy. Their research primarily focuses on Medicine, with a substantial number of publications, totalling over 600 works. Within the medical field, their contributions are especially concentrated in the subfields of Pathology and Forensic Medicine, Genetics, Oncology, Hematology, and Immunology.

The scientist's work spans several main topics, including:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Immunodeficiency and Autoimmune Disorders
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research

Gaidano has published extensively in several journals, with frequent contributions to:

  • Blood
  • Hematological Oncology
  • HemaSphere
  • Clinical Lymphoma Myeloma & Leukemia
  • Cancers

Notable recent papers include:

  • "Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study" (2020, The Lancet Oncology)
  • "Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA" (2021, Nature Biotechnology)
  • "Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer" (2020, Cancer Discovery)
  • "Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients" (2020, Scientific Reports)
  • "International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia" (2020, Blood)

The scientist has collaborated frequently with several co-authors, most notably:

  • Riccardo Moia
  • Davide Rossi
  • Valter Gattei
  • Andrea Patriarca
  • Robin Foà

Best Publications

  • Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia

    Jan A. Burger;Alessandra Tedeschi;Paul M. Barr;Tadeusz Robak

  • Analysis of the coding genome of diffuse large B-cell lymphoma

    Laura Pasqualucci;Vladimir Trifonov;Giulia Fabbri;Jing Ma

  • p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

    Gianluca Gaidano;Paola Ballerini;Jerry Z. Gong;Giorgio Inghirami

  • Inactivating mutations of acetyltransferase genes in B-cell lymphoma

    Laura Pasqualucci;David Dominguez-Sola;Annalisa Chiarenza;Giulia Fabbri

  • Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

    Meletios Athanasios Dimopoulos;Philippe Moreau;Antonio Palumbo;Douglas Edgar Joshua

  • Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

    Giulia Fabbri;Silvia Rasi;Davide Rossi;Vladimir A. Trifonov

  • Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

    Davide Rossi;Silvia Rasi;Valeria Spina;Alessio Bruscaggin

  • Genetics of Follicular Lymphoma Transformation

    Laura Pasqualucci;Hossein Khiabanian;Marco Fangazio;Mansi Vasishtha

  • Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

    Davide Rossi;Silvia Rasi;Giulia Fabbri;Valeria Spina

  • Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

    P. Knoebl;P. Marco;F. Baudo;Peter William Collins

  • Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

    Sara Bringhen;Alessandra Larocca;Davide Rossi;Maide Cavalli

  • Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.

    Davide Rossi;Alessio Bruscaggin;Valeria Spina;Silvia Rasi

  • Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.

    Ramona Crescenzo;Ramona Crescenzo;Francesco Abate;Francesco Abate;Francesco Abate;Elena Lasorsa;Fabrizio Tabbo;Fabrizio Tabbo

  • The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

    Davide Rossi;Valeria Spina;Clara Deambrogi;Silvia Rasi

  • The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development

    Davide Rossi;Vladimir Trifonov;Marco Fangazio;Alessio Bruscaggin

  • p53 mutations are associated with histologic transformation of follicular lymphoma

    F. Lo Coco;G. Gaidano;D. C. Louie;K. Offit

  • Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia

    Davide Rossi;Hossein Khiabanian;Valeria Spina;Carmela Ciardullo

  • The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.

    Davide Rossi;Michaela Cerri;Clara Deambrogi;Elisa Sozzi

  • Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

    Sergio Amadori;Stefan Suciu;Dominik Selleslag;Franco Aversa

  • Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

    P Baliakas;A Hadzidimitriou;L-A Sutton;D Rossi

Frequent Co-Authors

Davide Rossi
Davide Rossi European Society for Medical Oncology
Valter Gattei
Valter Gattei University of Trieste
Daniela Capello
Daniela Capello University of Eastern Piedmont Amadeo Avogadro
Francesco Bertoni
Francesco Bertoni Institute of Oncology Research
Annunziata Gloghini
Annunziata Gloghini University of Milan
Emanuele Zucca
Emanuele Zucca Universita della Svizzera Italiana
Robin Foà
Robin Foà Sapienza University of Rome
Luca Laurenti
Luca Laurenti Catholic University of the Sacred Heart
Antonino Carbone
Antonino Carbone Centro di Riferimento Oncologico
Giuseppe Saglio
Giuseppe Saglio University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a traditional medical degree in the USA is highly rewarding, but there are also several related online degrees and alternative career pathways in healthcare. For those interested in healthcare management, a him associate degree online offers a flexible way to enter the field of health information management, focusing on the organization and security of patient data.

Another popular option is medical administration, and there are many reputable medical billing and coding online courses that can prepare you for essential roles in healthcare facilities by teaching industry-standard coding systems.

For nursing professionals, advancing your education can significantly impact your career. The most affordable nurse practitioner programs are available online, enabling registered nurses to expand their scope of practice with minimal disruption to their schedules. If you’re a registered nurse seeking more affordable options, exploring the cheapest rn to bsn online degrees can help you advance your credentials and open up leadership opportunities.

These online pathways provide flexibility, accessibility, and a variety of specializations—empowering you to build a meaningful healthcare career outside the traditional medical school route.

Best Scientists Citing Gianluca Gaidano

Trending Scientists